Indosol Drugs Limited

This company manufactures and distributes pharmaceuticals, chemicals, and healthcare products globally.

1988 | Mumbai, Maharashtra (India) | Active
Last Updated:

Indosol Drugs Profile

Key Indicators

  • Authorised Capital ₹ 10.00 Cr
  • Paid Up Capital ₹ 7.50 Cr
  • Company Age 36 Year, 7 Months
  • Last Filing with ROC 31 Mar 2024
  • Satisfied Charges ₹ 18.96 Cr
  • Revenue Growth -28.30%
  • Profit Growth -11.66%
  • Ebitda -7.34%
  • Net Worth -2.11%
  • Total Assets -22.60%

About Indosol Drugs

Indosol Drugs Limited (IDL) is a Public Limited Indian Non-Government Company incorporated in India on 07 July 1988 and has a history of 36 years and seven months. Its registered office is in Mumbai, Maharashtra, India.

The Company is engaged in the Pharma Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 10.00 Cr and a paid-up capital of Rs 7.50 Cr.

The company has closed loans amounting to ₹18.96 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.

Niranjan Shah, Chirag Shah, and Virendra Shah serve as directors at the Company.

Company Details

  • Location

    Mumbai, Maharashtra, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

    indosolexports.com

  • Social Media
    -

Corporate Identity Details

  • CIN/LLPIN

    U24230MH1988PLC047992

  • Company No.

    047992

  • Company Classification

    Public Limited Indian Non-Government Company

  • Incorporation Date

    07 Jul 1988

  • Date of AGM

    30 Sep 2024

  • Date of Balance Sheet

    31 Mar 2024

  • Listing Status

    Unlisted

  • ROC Code

    Roc Mumbai

Industry

Pharma

Who are the key members and board of directors at Indosol Drugs?

Board Members (3)

NameDesignationAppointment DateStatus
Niranjan Shah Country flag representing In Director 06-Sep-2004Current
Chirag Shah Country flag representing In Director 23-Feb-1994Current
Virendra Shah Country flag representing In Director 07-Jul-1988Current

Financial Performance of Indosol Drugs.

Indosol Drugs Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 28.3% decrease. The company also saw a substantial fall in profitability, with a 11.66% decrease in profit. The company's net worth dipped by a decrease of 2.11%.

Indosol Drugs revenue growth over time
Indosol Drugs profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
-28.30%
Revenue from Operations
Total Assets
-22.60%
Profit or Loss
-11.66%
Net Worth
-2.11%
EBITDA
-7.34%

What is the Ownership and Shareholding Structure of Indosol Drugs?

In 2022, Indosol Drugs had a promoter holding of 45.33% and a public holding of 54.67%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Open Charges

₹0

Satisfied Charges

₹18.96 Cr

Charges Breakdown by Lending Institutions

  • Central Bank Of India : 18.96 Cr

Latest Charge Details

DateLenderAmountStatus
30 Apr 2002Central Bank Of India₹18.96 CrSatisfied

How Many Employees Work at Indosol Drugs?

Indosol Drugs has a workforce of 4 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee growth trends for Indosol Drugs Limited

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Indosol Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Indosol Drugs's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Indosol Drugs

Recent activity within the organization

  • Annual General Meeting

    Indosol Drugs Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.

  • Balance Sheet

    Indosol Drugs Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai.

  • Charges

    A charge registered on 30 Apr 2002 via Charge ID 90232806 with Central Bank Of India was fully satisfied on 27 Nov 2013.

  • Director Appointment

    Niranjan Popatlal Shah was appointed as a Director was appointed as a Director on 06 Sep 2004 & has been associated with this company since 20 years 5 months .

  • Charges

    A charge with Central Bank Of India amounted to Rs. 18.96 Cr with Charge ID 90232806 was registered on 30 Apr 2002.

  • Director Appointment

    Chirag Ashok Shah was appointed as a Director was appointed as a Director on 23 Feb 1994 & has been associated with this company since 31 years 10 days .

Frequently asked questions

  • What is the Incorporation or founding date of Indosol Drugs Limited?

    Indosol Drugs Limited was incorporated on 07 Jul 1988.

  • What is authorized share capital and paid-up capital of Indosol Drugs Limited?

    The authorized share capital of Indosol Drugs Limited is ₹ 10.00 Cr and paid-up capital is ₹ 7.50 Cr.

  • Who are the current board members & directors of Indosol Drugs Limited?

    Currently 3 directors are associated with Indosol Drugs Limited.

    • Niranjan Popatlal Shah
    • Chirag Ashok Shah
    • Virendra Popatlal Shah
  • What is the registered address of Indosol Drugs Limited?

    As per Ministry of Corporate Affairs (Mca), the registered address of Indosol Drugs Limited is 84- Floor-8 Plot-195 Arcadia Building Vinayak Kumar Shah Marg N C P A Narima Point, India, Mumbai, Maharashtra, 400021.

  • What is the corporate identification number (CIN) and company number of Indosol Drugs Limited?

    The corporate identification number (CIN) of Indosol Drugs Limited is U24230MH1988PLC047992 and the company number is 047992 as per Ministry of Corporate Affairs (MCA).

  • What is the official website of Indosol Drugs Limited?

    The Official website of Indosol Drugs Limited is https://www.indosolexports.com

  • What has been the recent revenue trend for Indosol Drugs Limited?

    According to the financial reports for the fiscal year 2022, the revenue trend for Indosol Drugs Limited has fallen by -28.30%.

  • How many employees does Indosol Drugs Limited currently have?

    As Per 2022 financial reports, 4 employees are currently employed by Indosol Drugs Limited.

  • What change has been observed in the net worth of Indosol Drugs Limited, and by what percentage?

    The financial reports for the fiscal year 2022 indicates that The net worth of Indosol Drugs Limited has experienced an downturn of -2.11%.

  • When was the last Balance Sheet of Indosol Drugs Limited filed with the ROC?

    The most recent Balance Sheet for Indosol Drugs Limited was filed with the ROC on 31 Mar 2024.